Staying private or going public? Which is best…. the view from the top?

Staying private or going public? Which is best…. the view from the top?

Access to capital and liquidity are important factors for C suite and investors alike. However going public comes with a different set of pressures – regulatory, communication demands etc.

This session will address both private and public CEOs to ask what lessons have been learned and if they would do it all again.

FACILITATED BY

PRIYA MANDE | Chief Operating Officer | PsiOxus Therapeutics

PANELLISTS INCLUDE

CLIVE DIX | Chief Executive Officer | C4X Discovery
STEVE HARRIS | Chairman | Synchrony Pharma
THEODORA HAROLD | Chief Executive Officer | Crescendo Biologics
JOHN DAWSON | Chief Executive Officer | Oxford Biomedica
ALLAN MARCHINGTON | Managing Partner & Senior Advisor | Bridge Valley Ventures & Apposite Capital